Healthcare: The Ever-Growing Industry

April 25th, 2017

As we mentioned in a previous blog, without a mandate for individuals and businesses to obtain or provide coverage, in addition to Medicaid rollbacks, we can expect significantly fewer insured individuals throughout the U.S. Nonetheless, the healthcare industry should continue its significant growth into the future, presenting worthwhile collection opportunities for the ARM industry.

Broadly speaking, the healthcare industry remains a consistent and stoic industry, able to endure virtually any type of problems, which makes it an even more appealing industry to ARM participants and investors alike. This industry grew in the past even during the recession before ACA’s implementation.

Looking more in-depth at the industry, in 2015, the most recent data available, hospitals (32.3% of total healthcare expenditures) made up the biggest segment in the sector, followed by physician and clinical expenditures (19.8%) and prescription drugs (10.1%). Other segments of the industry include, among others, home healthcare, nursing and retirement care, and dental services.

As we discussed in the previously mentioned blog, the ACA shifted the uncompensated care (bad debt) burden from hospitals to health insurers and consumers, many of whom were unable to make up the rising premium and deductible costs. If a bill similar to the AHCA is signed into law by Trump, then the uncompensated costs burden would likely shift back to the hospitals who’ll be forced to cover costs of the anticipated growth in uninsured low-income individuals. Additionally, a bill similar to the AHCA may lead to higher premiums for older individuals, thus, as more and more people need healthcare, the associated costs will go up, coupled with the elimination of protection from high premiums.

Overall, the healthcare industry should continue growing into the future, as it remains a vital aspect and necessity for U.S. residents. It’s reasonable to assume that healthcare opportunities for the ARM industry should persist regardless of what happens with an ACA repeal and replace bill; the only difference being who’s burdened to pay for uncompensated costs. Health insurers payments per enrollee should presumably decrease, which will be offset by increases in hospitals and physicians’ clinics. Lastly, healthcare is a necessity so regardless of the political reforms that may occur, people will continue to utilize its key services and goods.

Comments are closed.


Kaulkin Ginsberg is Changing the Way That Busy Executives Access Strategic Information

February 20, 2018

At Kaulkin Ginsberg, we have become very dissatisfied with the limitations ARM professionals face when accessing critical market intelligence. That's why we created KG Prime.....

» see this post    » all posts

Stock Market's Impact on the Economy & ARM Industry

February 13, 2018

Last week, the S&P 500 and Dow Jones indexes each fell by nearly 10%, before rebounding on February 9. What do fluctuations in the stock market actually mean, and what impacts do they have on the economy and the accounts receivable management industry?....

» see this post    » all posts

Is a Corporate Roll-Up Strategy Right for You?

February 8, 2018

Investment bankers and private equity firms use phrases like "industry consolidation plays" or "spoke and wheel models," but few ever explain what that actually means, and how it will benefit the business owner. Here, we outline the corporate roll-up process for business owners and clarify what they expect as the buyer in this process.....

» see this post    » all posts


Mike Ginsberg to speak at RMA's 2018 Annual Conference

January 9, 2018

Mike Ginsberg, president and CEO of Kaulkin Ginsberg, will be joining a panel of industry experts at RMA's 2018 Annual conference to discuss M&A and financing in the ARM industry.....

» see more

Kaulkin Ginsberg Company announces the addition of the U.S. federal government market segment on KG Prime.

December 5, 2017

As part of Kaulkin Ginsberg expanding market intelligence series on KG Prime, their market research team recently retrieved and examined data regarding the US federal government market segment.....

» see more

Kaulkin Ginsberg Company Teams up with Topline Valuation Group to Offer a New Valuation Service

November 21, 2017

Kaulkin Ginsberg, in conjunction with its sister company Topline Valuation Group, announces the release of a product that provides ARM company owners with an in-depth assessment of their company's strategic opportunities.....

» see more